---
title: "Addiction Prevention and Responsible Opioid Practices Act"
identifier: "114-S-3075"
congress: 114
bill_number: 3075
bill_type: "S"
version_code: "is"
version_type: "Introduced in Senate"
bill_url: "https://chamberzero.com/congresses/114/bills/s/3075"
source: "https://www.congress.gov/bill/114th-congress/senate-bill/3075"
site: "Chamber Zero"
site_url: "https://chamberzero.com"
rendered_at: "2026-06-03T22:35:06.537Z"
---
# Full Text Index

Full inline text is not available for this bill version in the current text index, but the section-level markdown is available below.

- [SECTION 1 Short title](/congresses/114/bills/s/3075/sections/1-section-one.md)
- [SECTION 2 Opioid action plan](/congresses/114/bills/s/3075/sections/2.md)
- [SECTION 3 Opioid informational documents](/congresses/114/bills/s/3075/sections/3.md)
- [SECTION 4 Strengthening considerations for DEA narcotic quotas](/congresses/114/bills/s/3075/sections/4.md)
- [SECTION 5 Continuing medical education and prescription drug monitoring program registration for prescribers](/congresses/114/bills/s/3075/sections/5.md)
- [SECTION 6 Report on prescriber education courses for medical and dental students](/congresses/114/bills/s/3075/sections/6.md)
- [SECTION 7 Requirements under Prescription Drug Monitoring Programs](/congresses/114/bills/s/3075/sections/7.md)
- [SECTION 8 Development of new pain-related measures under the Medicare hospital value-based purchasing program to eliminate financial incentives to over-prescribe opioids](/congresses/114/bills/s/3075/sections/8.md)
- [SECTION 9 National Academy of Medicine Study](/congresses/114/bills/s/3075/sections/9.md)
- [SECTION 10 Excise tax on opioid pain relievers](/congresses/114/bills/s/3075/sections/10.md)
- [SECTION 11 Opioid consumer abuse reduction program](/congresses/114/bills/s/3075/sections/11.md)
- [SECTION 12 GAO study](/congresses/114/bills/s/3075/sections/12.md)